PG-901

Overview

PG-901 is a full, selective MC5R agonist ( EC 50 = 0.072 nM for hMC5R). PG-901 is also a full antagonist at the hMC3R and the hMC4R ( K b : 1.0 nM and 0.53 nM, respectively). PG-901 significantly diminishes Cytokines ( IL-1α , IL-1β , IL-6 ). PG-901 increases glucose tolerance, reduces blood glucose, decreases retinal damage.

Application

Products | Products > Peptides | Products > Disease Areas > Visual System Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Retinopathy | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Melanocortin Receptor | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-P11469
• CAS No.: 322639-20-3
• Molecular Formula: C53H71N13O9
• Molecular Weight: 1034.21
• Purity: 99.35%
• Storage: Sealed storage, away from moisture. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (2.42 mM); Clear solution
• Availability: In-stock

Source

Original product source